Drug Giant AstraZeneca Launches Evinova to Quicken Clinical Trials
Evinova aims to use AI to design studies, automate cost calculations, and determine feasibility for drug testing.
Original source
Read on DecryptRelated market context
Coinbase launches AI agent accounts for automated trading and spending
Coinbase's AI agent accounts could revolutionize finance by enabling autonomous transactions, but they may also heighten market vo...
Citi Launches Crypto Platform to Tokenize Private Company Shares
Just in, Citi(Citigroup) is launching a crypto platform to tokenize and trade shares of late-stage private companies for instituti...
Piero Hincapié aims to leverage Qatar experience for 2026 World Cup as crypto meets football’s biggest stage
Hincapi's growth and crypto's integration into football could redefine fan engagement and player influence in future global sports...
Crypto’s World Cup play: Kraken, Chainlink, and Algorand stake claims while USMNT sits on the sidelines
The USMNT's lack of crypto partnerships highlights missed opportunities for fan engagement and revenue in a rapidly growing digita...
XRP aims for $0.90 as ETF demand battles selling pressure from whales
XRP is trading at $1.11, down roughly 17% from its June opening, having set a new 2026 low on June 5 and shed $8 billion in market...